Angewandte
Chemie
to DIFBO but lacks the fluorine atoms. The similar reac-
tivities of these two compounds suggest that the substantial
activating effect of the gem-difluoro group is directly bal-
anced by the stabilizing influence of the sulfur atom.
We next tested the reactivity of TMTH with azide-
functionalized biomolecules. Indirect evidence of the ability
of TMTH to selectively label azide-modified glycoproteins
was obtained in an azide-blocking experiment with TMTH
and phosphine–FLAG, which reacts with azides through
a Staudinger ligation.[18] Jurkat cells were treated with
peracetylated N-azidoacetylgalactosamine (Ac4GalNAz),
which metabolically labels cell-surface glycoproteins with
GalNAz residues and intracellular proteins with GlcNAz
residues.[19] Cell lysates were generated and incubated with
TMTH at concentrations ranging from 1 nm to 1 mm for
1.5 hours at room temperature. The progress of the reaction
was determined by the detection of unreacted azides with
500 mm phosphine–FLAG (Figure 1a). Western-blot analysis
The stability of thiaDIFBO provided an opportunity to
enhance reactivity through a more dramatic structural
modification: the contraction to a seven-membered thiacy-
cloheptyne ring, a motif that has not yet been explored in the
context of bioorthogonality. Krebs and Kimling reported in
the 1970s that 3,3,6,6-tetramethylthiacycloheptyne (TMTH,
10) is indeed a stable cycloalkyne, and that it is known to react
with phenyl azide and other 1,3 dipoles in a manner that
correlates with its increased ring strain, although specific rate
constants for the reaction with 1,3 dipoles were not
reported.[15] Furthermore, although acetic acid adds to 10
over 10000 times faster than to cyclooctyne, the rate constant
for this addition is 1.41 ꢀ 10À5 mÀ1 sÀ1,[5] which makes the
reaction significantly slower than the azide–alkyne cyclo-
addition reaction with the more temperate reagent OCT.
Given this precedent, we presumed that the smaller ring size
of TMTH would promote the cycloaddition with azides at
faster rates than exhibited by cyclooctyne, and that the methyl
groups at the propargylic positions would shield the alkyne
from unwanted side reactions.
We synthesized TMTH in a manner similar to that
reported previously (see Scheme S2 in the Supporting Infor-
mation).[15] Its reaction with benzyl azide in CD3CN pro-
ceeded cleanly with a second-order rate constant of (4.0 Æ
0.4)mÀ1 sÀ1, the fastest reported cycloalkyne–azide reaction to
date (see Figures S3 and S4 in the Supporting Information).
During the preparation of this manuscript, Banert and Plefka
reported that TMTH was more reactive than a DIBO-like
cyclooctyne in a 1,3-dipolar cycloaddition with nitrous
oxide,[16] a result that is consistent with our findings.
Motivated by our results, we sought to further enhance the
reactivity of thiacycloheptynes through the addition of a fused
aryl ring. We attempted to synthesize the seven-membered
thiaDIFBO analogue 11 in which the activating propargylic
gem-difluoro group was replaced with the stabilizing prop-
argylic gem-dimethyl group, but we were unable to isolate 11
or any identifiable oligomerization or degradation products
thereof (see Scheme S3 in the Supporting Information).
Compound 11 could be formed transiently, as evidenced by
the formation of triazole products when the final alkyne-
generating reaction was performed in the presence of benzyl
azide, but 11 was clearly too unstable for practical purposes.
We thus returned to TMTH, whose unique combination of
azide reactivity and stability prompted us to explore its
potential as a bioorthogonal reagent. Importantly, TMTH
proved to be stable in water and phosphate-buffered saline
(PBS) and far less reactive with biologically relevant thiols
than with azides (see Figures S5 and S6 in the Supporting
Information). TMTH is known to undergo oxidation in air to
form the corresponding diketone,[17] but we saw no evidence
for this particular side reaction in our experiments under
aqueous conditions. Some degradation of TMTH in water was
observed, giving a complex product mixture, but the process
was slow on the time scale of most biological labeling
experiments (see Figure S5 in the Supporting Information).
Figure 1. Pretreatment of Ac4GalNAz-labeled cell lysates with TMTH
(10) results in inhibition of phosphine–FLAG (PHOS–FLAG) labeling.
Jurkat cells were incubated with Ac4GalNAz (50 mm) or vehicle
(DMSO) for 3days, and then lysed. a) The lysates were treated with
TMTH (concentration 1 nm–1 mm) for 1.5 h followed by 500 mm
phosphine–FLAG overnight; b) the lysates were analyzed by Western
blot by using a primary anti-FLAG antibody and a secondary antibody
conjugated to horseradish peroxidase. India Ink staining confirmed
equal protein loading (see Figure S7 in the Supporting Information).
DMSO=dimethyl sulfoxide.
indicated that pretreatment with TMTH diminished phos-
phine–FLAG labeling of cell lysates in a dose-dependent
manner (Figure 1b), thus implying that TMTH reacts with
azide-bearing glycoproteins. Similar results were obtained
through a direct competition experiment between TMTH and
phosphine–FLAG (see Figures S8 and S9 in the Supporting
Information).
To obtain direct evidence of the reactivity of TMTH with
azides, we sought to demonstrate selective labeling of an
azide-functionalized protein. By expressing the small protein
barstar from B. cenocepacia (11.7 kDa) in a methionine
auxotrophic E. coli cell line, we generated a variant in
which both methionine (MET) residues were replaced with
azidohomoalanine (AHA) residues (barstar-AHA). The
Angew. Chem. Int. Ed. 2012, 51, 2443 –2447
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2445